Your browser doesn't support javascript.
loading
Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder.
Kennedy-Hendricks, Alene; Schilling, Cameron J; Busch, Alisa B; Stuart, Elizabeth A; Huskamp, Haiden A; Meiselbach, Mark K; Barry, Colleen L; Eisenberg, Matthew D.
Afiliação
  • Kennedy-Hendricks A; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Hampton House 408, Baltimore, MD, 21205, USA. alene@jhu.edu.
  • Schilling CJ; Johns Hopkins Center for Mental Health and Addiction Policy, Baltimore, MD, USA. alene@jhu.edu.
  • Busch AB; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Hampton House 408, Baltimore, MD, 21205, USA.
  • Stuart EA; Johns Hopkins Center for Mental Health and Addiction Policy, Baltimore, MD, USA.
  • Huskamp HA; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Meiselbach MK; McLean Hospital, Belmont, MA, USA.
  • Barry CL; Johns Hopkins Center for Mental Health and Addiction Policy, Baltimore, MD, USA.
  • Eisenberg MD; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
J Gen Intern Med ; 37(4): 769-776, 2022 03.
Article em En | MEDLINE | ID: mdl-34405345
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article